FDA clears laser device for BPH

January 19, 2006

Trimedyne, Inc., Irvine, CA, has received FDA approval to market its VaporMAX Fiber for use with its Holmium lasers to treat BPH.

Trimedyne, Inc., Irvine, CA, has received FDA approval to market its VaporMAX Fiber for use with its Holmium lasers to treat BPH. The new side-firing laser fibers vaporize an average of 3 grams of soft tissue over 60 minutes of use. This faster vaporization rate minimizes physician and operating room time, according to the company.

The company also said that product testing has indicated that the fibers are more durable than other side-firing fibers, meaning that one device should be sufficient to treat even large prostates.